Application of Radiomics in Breast Cancer

Recruiting

• Conditions: Pathology; Radiomics; Elastography; Breast Cancer; Ultrasound
• Interventions: Combination Product: Endocrine therapy

• Registration Number: NCT04483804
• Lead Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Brief Summary

Little is known about the correlation between ultrasound characteristics (conventional, elastography and contrast enhanced ultrasound (CEUS) )and pathological prognostic factors in breast cancer. The aim of this study was to explore the correlation between ultrasound characteristics and pathological prognostic factors using radiomics.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-01-01
• Study First Submitted: 2020-05-13
• Study First Submitted QC: 2020-07-20
• Study First Posted: 2020-07-23
• Status Verified: 2022-12
• Last Update Submitted: 2023-03-09
• Last Update Posted: 2023-03-10
• Primary Completion: 2023-12
• Study Completion: 2028-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

Clinical diagnosis of breast cancer

Exclusion Criteria

Missing pathology Missing follow-up results Missing data

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
disease free survival	Endocrine therapy	Time from randomization to relapse or death due to disease progression
non-disease free survival	Endocrine therapy	Time of metastasis or death

Primary Outcome Measures

Name	Time	Method
metastasis	through study completion, an average of 1 year	lymph node metastasis and/or distant metastasis
death	through study completion, an average of 1 year	death

Trial Locations

Locations (1)

the Second Affiliated Hospital Zhejiang University School of Medicine; 🇨🇳 Hanzhou, Zhejiang, China